Growth and Chemosensitivity of Gastric Adenocarcinoma and Non-Malignant Cell Lines in Response to Novel Anti-Cancer Drug Combinations

Publisher： Karger

E-ISSN： 1421-9794|60|5-6|346-352

ISSN： 0009-3157

Source： Chemotherapy, Vol.60, Iss.5-6, 2015-0, pp. : 346-352

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Schedule-Dependent Synergistic Effect of Pemetrexed Combined with Gemcitabine against Malignant Pleural Mesothelioma and Non-Small Cell Lung Cancer Cell Lines

By  

Chemotherapy, Vol. 54, Iss. 3, 2008-06 ,pp. : 166-175

Karger

Access to resources Recommend Favorite

Interference by Anti-Cancer Chemotherapeutic Agents in the MTT-Tumor Chemosensitivity Assay

By  

Chemotherapy, Vol. 50, Iss. 1, 2004-04 ,pp. : 43-50

Karger

Access to resources Recommend Favorite

Hsp90 Inhibitors and the Reduction of Anti-Cancer Drug Resistance by Non-Genetic and Genetic Mechanisms

By Lu Xiangyi   Wang Luan   Ruden Douglas M.  

Pharmaceuticals, Vol. 5, Iss. 9, 2012-08 ,pp. : 890-898

MDPI

Access to resources Recommend Favorite

Drug Treatment of Cancer Cell Lines: A Way to Select for Cancer Stem Cells?

By Chiodi Ilaria   Belgiovine Cristina   Donà Francesca   Scovassi A. Ivana   Mondello Chiara  

Cancers, Vol. 3, Iss. 1, 2011-03 ,pp. : 1111-1128

MDPI

Access to resources Recommend Favorite

Positive Response to Thermobalancing Therapy Enabled by Therapeutic Device in Men with Non-Malignant Prostate Diseases: BPH and Chronic Prostatitis

By Aghajanyan Ivan Gerasimovich   Allen Simon  

Diseases, Vol. 4, Iss. 2, 2016-04 ,pp. : 18-18

MDPI

Access to resources Recommend Favorite